ECOG-ACRIN EAY131-S1

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling

Status:

Closed

MATCH Treatment Subprotocol S1: EAY131-S1: Phase II Study of Trametinib in Patients with Tumors with NF1 mutations

(See required screening study ECOG-ACRIN EAY131)

NCT#02465060

Effective immediately, 06/15/18, EAY131-S1 is formally closed to accrual, as it has reached its enrollment goal.